294 related articles for article (PubMed ID: 31180333)
21. Parkin Mutation Affects Clock Gene-Dependent Energy Metabolism.
Pacelli C; Rotundo G; Lecce L; Menga M; Bidollari E; Scrima R; Cela O; Piccoli C; Cocco T; Vescovi AL; Mazzoccoli G; Rosati J; Capitanio N
Int J Mol Sci; 2019 Jun; 20(11):. PubMed ID: 31195749
[TBL] [Abstract][Full Text] [Related]
22. Association of DJ-1 and parkin mediated by pathogenic DJ-1 mutations and oxidative stress.
Moore DJ; Zhang L; Troncoso J; Lee MK; Hattori N; Mizuno Y; Dawson TM; Dawson VL
Hum Mol Genet; 2005 Jan; 14(1):71-84. PubMed ID: 15525661
[TBL] [Abstract][Full Text] [Related]
23. Mitochondria-Endoplasmic Reticulum Contact Sites Dynamics and Calcium Homeostasis Are Differentially Disrupted in PINK1-PD or PRKN-PD Neurons.
Grossmann D; Malburg N; Glaß H; Weeren V; Sondermann V; Pfeiffer JF; Petters J; Lukas J; Seibler P; Klein C; Grünewald A; Hermann A
Mov Disord; 2023 Oct; 38(10):1822-1836. PubMed ID: 37449534
[TBL] [Abstract][Full Text] [Related]
24. Parkin protects mitochondrial genome integrity and supports mitochondrial DNA repair.
Rothfuss O; Fischer H; Hasegawa T; Maisel M; Leitner P; Miesel F; Sharma M; Bornemann A; Berg D; Gasser T; Patenge N
Hum Mol Genet; 2009 Oct; 18(20):3832-50. PubMed ID: 19617636
[TBL] [Abstract][Full Text] [Related]
25. Effect of endogenous mutant and wild-type PINK1 on Parkin in fibroblasts from Parkinson disease patients.
Rakovic A; Grünewald A; Seibler P; Ramirez A; Kock N; Orolicki S; Lohmann K; Klein C
Hum Mol Genet; 2010 Aug; 19(16):3124-37. PubMed ID: 20508036
[TBL] [Abstract][Full Text] [Related]
26. A mitochondria-targeted caffeic acid derivative reverts cellular and mitochondrial defects in human skin fibroblasts from male sporadic Parkinson's disease patients.
Deus CM; Pereira SP; Cunha-Oliveira T; Teixeira J; Simões RF; Cagide F; Benfeito S; Borges F; Raimundo N; Oliveira PJ
Redox Biol; 2021 Sep; 45():102037. PubMed ID: 34147843
[TBL] [Abstract][Full Text] [Related]
27. Assessing the relationship between monoallelic PRKN mutations and Parkinson's risk.
Lubbe SJ; Bustos BI; Hu J; Krainc D; Joseph T; Hehir J; Tan M; Zhang W; Escott-Price V; Williams NM; Blauwendraat C; Singleton AB; Morris HR;
Hum Mol Genet; 2021 Mar; 30(1):78-86. PubMed ID: 33448283
[TBL] [Abstract][Full Text] [Related]
28. Heterozygous PRKN mutations are common but do not increase the risk of Parkinson's disease.
Zhu W; Huang X; Yoon E; Bandres-Ciga S; Blauwendraat C; Billingsley KJ; Cade JH; Wu BP; Williams VH; Schindler AB; Brooks J; Gibbs JR; Hernandez DG; Ehrlich D; Singleton AB; Narendra DP
Brain; 2022 Jun; 145(6):2077-2091. PubMed ID: 35640906
[TBL] [Abstract][Full Text] [Related]
29. Intracellular delivery of Parkin-RING0-based fragments corrects Parkin-induced mitochondrial dysfunction through interaction with SLP-2.
Zanon A; Guida M; Lavdas AA; Corti C; Castelo Rueda MP; Negro A; Pramstaller PP; Domingues FS; Hicks AA; Pichler I
J Transl Med; 2024 Jan; 22(1):59. PubMed ID: 38229174
[TBL] [Abstract][Full Text] [Related]
30. PRKN-regulated mitophagy and cellular senescence during COPD pathogenesis.
Araya J; Tsubouchi K; Sato N; Ito S; Minagawa S; Hara H; Hosaka Y; Ichikawa A; Saito N; Kadota T; Yoshida M; Fujita Y; Utsumi H; Kobayashi K; Yanagisawa H; Hashimoto M; Wakui H; Ishikawa T; Numata T; Kaneko Y; Asano H; Yamashita M; Odaka M; Morikawa T; Nishimura SL; Nakayama K; Kuwano K
Autophagy; 2019 Mar; 15(3):510-526. PubMed ID: 30290714
[TBL] [Abstract][Full Text] [Related]
31. N370S-GBA1 mutation causes lysosomal cholesterol accumulation in Parkinson's disease.
García-Sanz P; Orgaz L; Bueno-Gil G; Espadas I; Rodríguez-Traver E; Kulisevsky J; Gutierrez A; Dávila JC; González-Polo RA; Fuentes JM; Mir P; Vicario C; Moratalla R
Mov Disord; 2017 Oct; 32(10):1409-1422. PubMed ID: 28779532
[TBL] [Abstract][Full Text] [Related]
32. Control of mitochondrial integrity in Parkinson's disease.
Vives-Bauza C; Tocilescu M; Devries RL; Alessi DM; Jackson-Lewis V; Przedborski S
Prog Brain Res; 2010; 183():99-113. PubMed ID: 20696317
[TBL] [Abstract][Full Text] [Related]
33. [Parkin and mitochondria].
Mitsui T; Kuroda Y; Kaji R
Brain Nerve; 2008 Aug; 60(8):923-9. PubMed ID: 18717196
[TBL] [Abstract][Full Text] [Related]
34. Mitochondrial dysfunction induced by knockdown of mortalin is rescued by Parkin.
Yang H; Zhou X; Liu X; Yang L; Chen Q; Zhao D; Zuo J; Liu W
Biochem Biophys Res Commun; 2011 Jun; 410(1):114-20. PubMed ID: 21640711
[TBL] [Abstract][Full Text] [Related]
35. A53T human α-synuclein overexpression in transgenic mice induces pervasive mitochondria macroautophagy defects preceding dopamine neuron degeneration.
Chen L; Xie Z; Turkson S; Zhuang X
J Neurosci; 2015 Jan; 35(3):890-905. PubMed ID: 25609609
[TBL] [Abstract][Full Text] [Related]
36. Decreased amount of vimentin N-terminal truncated proteolytic products in parkin-mutant skin fibroblasts.
Siciliano RA; Mazzeo MF; Ferretta A; Pacelli C; Rosato A; Papa F; Scacco S; Papa S; Cocco T; Lippolis R
Biochem Biophys Res Commun; 2020 Jan; 521(3):693-698. PubMed ID: 31699368
[TBL] [Abstract][Full Text] [Related]
37. Parkin mRNA Expression Levels in Peripheral Blood Mononuclear Cells in Parkin-Related Parkinson's Disease.
Papagiannakis N; Liu H; Koros C; Simitsi AM; Stamelou M; Maniati M; Buena-Atienza E; Kartanou C; Karadima G; Makrythanasis P; Vatsellas G; Valente EM; Gasser T; Stefanis L
Mov Disord; 2024 Apr; 39(4):715-722. PubMed ID: 38357851
[TBL] [Abstract][Full Text] [Related]
38. Mitochondrial DNA heteroplasmy distinguishes disease manifestation in PINK1/PRKN-linked Parkinson's disease.
Trinh J; Hicks AA; König IR; Delcambre S; Lüth T; Schaake S; Wasner K; Ghelfi J; Borsche M; Vilariño-Güell C; Hentati F; Germer EL; Bauer P; Takanashi M; Kostić V; Lang AE; Brüggemann N; Pramstaller PP; Pichler I; Rajput A; Hattori N; Farrer MJ; Lohmann K; Weissensteiner H; May P; Klein C; Grünewald A
Brain; 2023 Jul; 146(7):2753-2765. PubMed ID: 36478228
[TBL] [Abstract][Full Text] [Related]
39. Identification of bioactive metabolites in human iPSC-derived dopaminergic neurons with PARK2 mutation: Altered mitochondrial and energy metabolism.
Okarmus J; Havelund JF; Ryding M; Schmidt SI; Bogetofte H; Heon-Roberts R; Wade-Martins R; Cowley SA; Ryan BJ; Færgeman NJ; Hyttel P; Meyer M
Stem Cell Reports; 2021 Jun; 16(6):1510-1526. PubMed ID: 34048689
[TBL] [Abstract][Full Text] [Related]
40. LRRK2 impairs PINK1/Parkin-dependent mitophagy via its kinase activity: pathologic insights into Parkinson's disease.
Bonello F; Hassoun SM; Mouton-Liger F; Shin YS; Muscat A; Tesson C; Lesage S; Beart PM; Brice A; Krupp J; Corvol JC; Corti O
Hum Mol Genet; 2019 May; 28(10):1645-1660. PubMed ID: 30629163
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
